|Minimum Order Quantity||1 Box|
|Packaging size||2x10 Capsules|
|Shelf life||2 years|
LENVIMA is used for the treatment of adult patients with progressive, locally advanced or metastatic, radioactive iodine-refractory differentiated thyroid cancer (RAI-refractory DTC)
The recommended daily dose is 24mg (two 10-mg capsules plus one 4-mg capsule)
LENVIMA should be taken at the same time each day. If a patient misses a dose, and it cannot be taken within 12 hours, then that dose should be skipped, and the next dose should be taken at the usual time of administration.
The most common side effects of LENVIMA include tiredness; joint and muscle pain; decreased appetite; weight loss; nausea; mouth sores; headache; vomiting; rash, redness, itching, or peeling of the skin on your hands and feet; stomach (abdomen) pain; and hoarseness.
Tell your doctor if you have serious side effects of Lenvima including pneumonia or dehydration